MUC16 / CA125 Antibody (aa13311-13360)
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application ![]()
| IHC-P, IF, E |
---|---|
Primary Accession | Q8WXI7 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 2353kDa |
Dilution | ELISA (1:20000), IF (1:100-1:500), IHC-P (10 µg/ml) |
Gene ID | 94025 |
---|---|
Other Names | Mucin-16, MUC-16, Ovarian cancer-related tumor marker CA125, CA-125, Ovarian carcinoma antigen CA125, MUC16, CA125 |
Target/Specificity | MUC16 Antibody detects endogenous levels of total MUC16 protein. |
Reconstitution & Storage | Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. |
Precautions | MUC16 / CA125 Antibody (aa13311-13360) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | MUC16 (HGNC:15582) |
---|---|
Function | Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces. |
Cellular Location | Cell membrane; Single-pass type I membrane protein. Secreted, extracellular space. Note=May be liberated into the extracellular space following the phosphorylation of the intracellular C-terminus which induces the proteolytic cleavage and liberation of the extracellular domain |
Tissue Location | Expressed in corneal and conjunctival epithelia (at protein level). Overexpressed in ovarian carcinomas and ovarian low malignant potential (LMP) tumors as compared to the expression in normal ovarian tissue and ovarian adenomas |
Volume | 50 µl |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.
References
O'Brien T.J.,et al.Tumor Biol. 23:154-169(2002).
O'Brien T.J.,et al.Tumor Biol. 22:348-366(2001).
Yin B.W.T.,et al.J. Biol. Chem. 276:27371-27375(2001).
Lloyd K.O.,et al.Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.